0 items USD 0.00Search
- Did you mean
- closing spondylitis
Your search for "Ankylosing spondylitis" gave back 113 results.
The global Enbrel (Etanercept) Biosimilar market size is projected to grow from US$ 1219.9 million in 2022 to US$ 1688.2 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
Adalimumab, sold under the brand name Humira, among others, is a monoclonal antibody used to treat rheumatoid arthritis, psoriatic arthritis,...
Catalog:
MRRPB5
April 2024
Price: USD 2,900.00
Knee and hip are complex joints in the body. The knee joins the thigh bone (femur) to the shin bone (tibia), whereas the hip joint is a ball-socket...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Enbrel (Etanercept) and Biosimilar market size is projected to grow from US$ 6211.9 million in 2022 to US$ 7862.4 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Acemetacin market size was valued at US$ million in 2023. With growing demand in downstream market, the Acemetacin is forecast to a...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Acemetacin (CAS 53164-05-9) is a carboxylic ester that is the carboxymethyl ester of indometacin. A non-steroidal anti-inflammatory drug, it is used...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Certolizumab pegol (CDP870, tradename Cimzia) is a biologic medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The global Enbrel (Etanercept) and Biosimilar market size is expected to reach $ 8122.5 million by 2029, rising at a market growth of 3.2% CAGR...
Catalog:
GIR
June 2023
Price: USD 4,480.00
Ketorolac is a Non-steroidal anti-inflammatory drug (NSAID) and is commercially available as an oral tablet, injectable, nasal spray and as an...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
The biologics used in Anti-inflammatory treatment – abatacept (Orencia), adalimumab (Humira), anakinra (Kineret), etanercept (Enbrel), infliximab (...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Celecoxib API refers to the active pharmaceutical ingredient (API) of the drug Celecoxib, which is a non-steroidal anti-inflammatory drug (NSAID)...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Celecoxib API market size was valued at US$ 55 million in 2023. With growing demand in downstream market, the Celecoxib API is forecast to...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Adalimumab, sold under the trade name Humira among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The global Enbrel (Etanercept) and Biosimilar market size was valued at USD 6533.8 million in 2022 and is forecast to a readjusted size of USD 8122.5...
Catalog:
GIR
June 2023
Price: USD 3,480.00
The global Enbrel (Etanercept) Biosimilar market size was valued at USD 1283.1 million in 2022 and is forecast to a readjusted size of USD 1732.5...
Catalog:
GIR
June 2023
Price: USD 3,480.00
